Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine continuous wound infiltration after adolescent idiopathic scoliosis surgery
ChiCTR2000038967Phase 4Completed
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Jan 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ropivacaine in postoperative pain (2 arms), sponsored by Shanghai Changzheng Hospital. Primary endpoints: visual analog scale and PCA consumption. Started Jan 2020; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2000038967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038967.